S
Sam Fazio
Researcher at Alzheimer's Association
Publications - 28
Citations - 2774
Sam Fazio is an academic researcher from Alzheimer's Association. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 10, co-authored 19 publications receiving 2108 citations.
Papers
More filters
Journal ArticleDOI
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective.
TL;DR: There is sufficiently strong evidence, from a population‐based perspective, to conclude that regular physical activity and management of cardiovascular risk factors reduce the risk of cognitive decline and may reduce therisk of dementia.
Journal ArticleDOI
Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy
Javier Olazarán,Barry Reisberg,Linda Clare,Isabel Cruz,Jordi Peña-Casanova,Teodoro Del Ser,Bob Woods,Cornelia Beck,Stefanie Auer,Claudia K.Y. Lai,Aimee Spector,Sam Fazio,John Bond,Miia Kivipelto,Henry Brodaty,José Manuel Rojo,Helen Collins,Linda Teri,Mary S. Mittelman,Martin Orrell,Howard Feldman,Ruben Muñiz +21 more
TL;DR: NPTs emerge as a useful, versatile and potentially cost-effective approach to improve outcomes and QoL in ADRD for both the PWD and CG.
Journal ArticleDOI
The Fundamentals of Person-Centered Care for Individuals With Dementia.
TL;DR: The history, components, and impact of person-centered care practices, a philosophy of care built around the needs of the individual and contingent upon knowing the unique individual through an interpersonal relationship, are outlined.
Journal ArticleDOI
Alzheimer's Association Dementia Care Practice Recommendations.
TL;DR: The history, components, and impact of person-centered care practices, a philosophy of care built around the needs of the individual and contingent upon knowing the unique individual through an interpersonal relationship, are outlined.
Journal ArticleDOI
Diagnosis and assessment of Alzheimer's disease in diverse populations
TL;DR: A think tank was convened to discuss how Alzheimer’s disease affects various communities differently and how its diagnosis and treatment present challenges specific to certain population groups.